As of today (2024-05-14), Veracyte's share price is $22.50. Veracyte's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $3.25. Hence, Veracyte's Price to Tangible Book Ratio of today is 6.92.
The historical rank and industry rank for Veracyte's Price-to-Tangible-Book or its related term are showing as below:
VCYT'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.14 Med: 7.96 Max: 26.31
Current: 6.92
During the past 13 years, Veracyte's highest Price to Tangible Book Ratio was 26.31. The lowest was 3.14. And the median was 7.96.
VCYT's Price-to-Tangible-Book is ranked worse than 82.53% of 166
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.505
vs VCYT: 6.92
A closely related ratio is called PB Ratio. As of today, Veracyte's share price is $22.50. Veracyte's Book Value per Sharefor the quarter that ended in Mar. 2024 was $14.64. Hence, Veracyte's P/B Ratio of today is 1.54.
Veracyte Price-to-Tangible-Book Historical Data
The historical data trend for Veracyte's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Veracyte's Price-to-Tangible-Book
For the Diagnostics & Research subindustry, Veracyte's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veracyte's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Veracyte's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Veracyte's Price-to-Tangible-Book falls into.
Veracyte Price-to-Tangible-Book Calculation
Veracyte's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Veracyte Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Veracyte's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VCYT has been successfully added to your 